AMSF vs GLRE

AMSF's Piotroski F-Score of 3/9 indicates weak financial health, with no Altman Z-Score available to confirm solvency. Despite a defensive Graham Number of $27.28 and an intrinsic value estimate of $17.29, the stock trades at $32.85—significantly above both benchmarks. This suggests overvaluation, especially given deteriorating earnings growth (-19.2% YoY) and a recent streak of missed earnings (0/4 beats in last 4 quarters). The bearish technical trend and negative insider activity further undermine confidence.

GLRE presents a classic value trap profile: fundamentally undervalued but plagued by poor earnings quality and bearish internal sentiment. The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while the stock trades at a significant discount to its Graham Number ($32.3) and below book value (P/B 0.90). Despite strong top-line revenue growth of 39.7%, the catastrophic YoY EPS decline of -134.3% and consistent earnings misses suggest operational instability. The valuation is attractive, but the combination of bearish insider selling and poor earnings track record offsets the value proposition.